| 000 | 01647 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250514030622.0 | ||
| 264 | 0 | _c20020712 | |
| 008 | 200207s 0 0 eng d | ||
| 022 | _a0300-5526 | ||
| 024 | 7 |
_a10.1159/000050085 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTsubota, Akihito | |
| 245 | 0 | 0 |
_aViral dynamics and pharmacokinetics in combined interferon alfa-2b and ribavirin therapy for patients infected with hepatitis C virus of genotype 1b and high pretreatment viral load. _h[electronic resource] |
| 260 |
_bIntervirology _c2002 |
||
| 300 |
_a33-42 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntiviral Agents _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 |
_aHepacivirus _xclassification |
| 650 | 0 | 4 |
_aHepatitis C, Chronic _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInterferon alpha-2 |
| 650 | 0 | 4 |
_aInterferon-alpha _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aRNA, Viral _xblood |
| 650 | 0 | 4 | _aRecombinant Proteins |
| 650 | 0 | 4 |
_aRibavirin _xadministration & dosage |
| 650 | 0 | 4 | _aViral Load |
| 700 | 1 | _aAkuta, Norio | |
| 700 | 1 | _aSuzuki, Fumitaka | |
| 700 | 1 | _aSuzuki, Yoshiyuki | |
| 700 | 1 | _aSomeya, Takahi | |
| 700 | 1 | _aKobayashi, Masahiro | |
| 700 | 1 | _aArase, Yasuji | |
| 700 | 1 | _aSaitoh, Satoshi | |
| 700 | 1 | _aIkeda, Kenji | |
| 700 | 1 | _aKumada, Hiromitsu | |
| 773 | 0 |
_tIntervirology _gvol. 45 _gno. 1 _gp. 33-42 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000050085 _zAvailable from publisher's website |
| 999 |
_c11841675 _d11841675 |
||